Genmab
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Genmab
RECRUITINGPhase 3NCT07225270
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance...
This Phase 3 study will be conducted in different countries around the world with up to about 528 participants. The purpose of this study is to evaluate how well Rina-S works...
Sponsor: GenmabEnrolling: 5282 locations
Ovarian CancerPlatinum-sensitive Ovarian CancerPSOC
RECRUITINGPhase 2NCT05283720
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With...
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (a white blood cell responsible for fighting infections). The purpose of this study is to assess the...
Sponsor: GenmabEnrolling: 49620 locations
Non-Hodgkin Lymphoma
RECRUITINGPhase 1 / Phase 2NCT05579366
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
This study will test the safety, including side effects, and determine the characteristics of a drug called Rina-S in participants with solid tumors. Participants will have solid...
Sponsor: GenmabEnrolling: 76420 locations
High Grade Epithelial Ovarian CancerHigh Grade Serous Ovarian CancerPrimary Peritoneal Carcinoma+12